ReWalk Robotics Ltd. (Nasdaq: RWLK), the leading global exoskeleton manufacturer, unveiled today the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking the ...
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...
* REWALK ROBOTICS - AGREEMENT TO ALLOW ANY ELIGIBLE BENEFICIARY WITH SPINAL CORD INJURY IN COUNTRY TO SEEK PROCUREMENT OF REWALK 6.0 EXOSKELETON SYSTEM * REWALK ROBOTICS - ELIGIBLE BENEFICIARIES WILL ...
Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Rewalk Robotics (RWLK – Research Report), with a price target of $3.00. Swayampakula Ramakanth’s rating for Rewalk Robotics ...
Lifeward Ltd. LFWD recently launched the ReWalk 7 Personal Exoskeleton in the U.S. market, marking another milestone in assistive technology for individuals with spinal cord injuries. This ...
Lifeward Ltd. reported its financial results for the first quarter of 2025, highlighting a continuing build-up of opportunities for the ReWalk exoskeleton with over 120 qualified leads. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results